TheraRadar
← Back
Data updated: Mar 29, 2026

MORTON GROVE

GastroenterologyCardiovascular
Generics

MORTON GROVE is a generic drug manufacturer focused on Gastroenterology, Cardiovascular.

1989
Since
16
Drugs
-
Trials
74
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

NYSTATIN 2026-02-05
HALOPERIDOL 2025-12-18
TRIAMCINOLONE ACETONIDE 2025-10-17
TRIAMCINOLONE ACETONIDE 2025-10-08
Labeling
METOCLOPRAMIDE HYDROCHLORIDE 2025-08-01
Labeling
METOCLOPRAMIDE HYDROCHLORIDE 2025-08-01
Labeling
SODIUM POLYSTYRENE SULFONATE 2025-06-10
TRIAMCINOLONE ACETONIDE 2025-04-11
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 67%
2 drugs
Cardiovascular 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

BAUSCH specialty
Cardiovascular, Gastroenterology
APOTHECON specialty
Cardiovascular, Gastroenterology
VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Gastroenterology
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology